2-20006173-G-A
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PM1PM5PP3_StrongPP5_Very_Strong
The NM_002381.5(MATN3):c.361C>T(p.Arg121Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000041 in 1,461,648 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R121Q) has been classified as Likely pathogenic.
Frequency
Consequence
NM_002381.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
MATN3 | NM_002381.5 | c.361C>T | p.Arg121Trp | missense_variant | 2/8 | ENST00000407540.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
MATN3 | ENST00000407540.8 | c.361C>T | p.Arg121Trp | missense_variant | 2/8 | 1 | NM_002381.5 | P1 | |
MATN3 | ENST00000421259.2 | c.361C>T | p.Arg121Trp | missense_variant | 2/7 | 1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.00000410 AC: 6AN: 1461648Hom.: 0 Cov.: 33 AF XY: 0.00000550 AC XY: 4AN XY: 727102
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Multiple epiphyseal dysplasia type 5 Pathogenic:3
Likely pathogenic, criteria provided, single submitter | clinical testing | Johns Hopkins Genomics, Johns Hopkins University | Mar 31, 2021 | This MATN3 variant (rs104893637) is absent from a large population dataset and has an entry in ClinVar. It has been identified in approximately 40 percent of individuals with EDM5. Three bioinformatics tools queried predict that p.Arg121Trp would be damaging. The arginine residue at this position is conserved across most vertebrate species assessed. Analysis of cartilage from a patient with the p.Arg121Trp variant showed retention of matrilin-3 protein within the rough endoplasmic reticulum (rER) of chondrocytes. This variant is not predicted to affect normal exon 2 splicing, although this has not been confirmed experimentally to our knowledge. We consider c.361C>T to be likely pathogenic. - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Jan 01, 2004 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Genetics and Molecular Pathology, SA Pathology | Sep 07, 2022 | The MATN3 c.361C>T variant is classified as a PATHOGENIC variant (PS4, PM1, PM2, PP3, PP4) This variant is a single nucleotide change in the MATN3 gene which is predicted to change the amino acid arginine at position 121 in the protein to tryptophan. The variant is in exon 2/8 of the MATN3 gene and is located in protein domain: von Willebrand factor A-like domain (vWF A-domain), of the MATN3 gene. Studies have demonstrated that MED mutations in MATN3 are predominantly located in exon 2, which encodes the vWF A-domain (PMID: 16287128; 15459972) (PM1). The variant has been reported in dbSNP (rs104893637) but is absent from population databases (PM2). This variant has been known as a common disease causing variant in the MATN3 gene, and has been reported many times in individuals affected with MED (PMID: 11479597, 21965141, 14729835, 16287128, 15459972, GeneReview) (PS4). The variant has been reported in ClinVar (Variation ID: 7541) as likely pathogenic (1)/ pathogenic (2). The variant has been reported in HGMD (Accession#: CM012401) as disease causing. Computational predictions support a deleterious effect on the gene or gene product (PP3). Patient's phenotype is highly specific for a the MATN3 gene (PP4). - |
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Apr 27, 2023 | For these reasons, this variant has been classified as Pathogenic. Experimental studies have shown that this missense change affects MATN3 function (PMID: 16199550, 18518980). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt MATN3 protein function. ClinVar contains an entry for this variant (Variation ID: 7541). This missense change has been observed in individual(s) with multiple epiphyseal dysplasia (PMID: 11479597, 14729835). It has also been observed to segregate with disease in related individuals. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 121 of the MATN3 protein (p.Arg121Trp). - |
Pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jan 01, 2020 | - - |
Spondyloepimetaphyseal dysplasia, matrilin-3 type Pathogenic:1
Pathogenic, no assertion criteria provided | clinical testing | Laboratory of Genetic Skeletal Anomaly, Seoul National University Children's Hospital | - | - - |
Multiple epiphyseal dysplasia Other:1
not provided, no classification provided | literature only | GeneReviews | - | European-based studies have identified p.Arg121Trp in 12/33 and p.Thr120Met in 5/33 affected individuals (total = 52%) [Chapman et al 2001; Mostert et al 2003; Jackson et al 2004; Cotterill et al 2005; Fresquet et al 2007; Jackson et al 2012; Author, unpublished data]. In a Japanese population, p.Arg121Trp was identified in 3/9 and p.Thr120Met in 3/9 affected individuals (total = 66%) [Mabuchi et al 2004, Itoh et al 2006]. In a Korean study, p.Arg121Trp was identified in 20/30 and p.Thr120Met was identified in 4/30 affected individuals (total = 80%) [Kim et al 2011]. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at